Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III
Chike Bellarmine Item(Medical University of Vienna), Olaf A. Bodamer(Broad Institute), Ivana Mihalek(Boston Children's Hospital), Adolf Mühl(Medical University of Vienna), Julia Vodopiutz(Medical University of Vienna), Anil Jalan, Oliver Lichtarge(Baylor College of Medicine)
Cited by 24
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326
Phenylketonuria Scientific Review Conference: State of the science and future research needs
|Molecular Genetics and Metabolism|2014|271
Kabuki syndrome: international consensus diagnostic criteria
|Journal of Medical Genetics|2018|251